Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Alfacell elucidates action of Onconase

April 22, 1997

PLC-inhibitory peptides from Kyowa Hakko

April 22, 1997

Inflazyme licences anticancer drugs

April 21, 1997

Antimetastatic activity of Neovastat reported at AACR meeting

April 21, 1997

Antitumor/antibacterial agent isolated by Microbial Chemistry Research Foundation

April 21, 1997

Mercian discloses novel anthracycline antibiotics

April 21, 1997

Agouron anticancer research presented at AACR

April 21, 1997

Vertex and BioChem Pharma test VX-710 for breast cancer and soft tissue sarcoma

April 21, 1997

German launch for Femara

April 21, 1997

PDT expands phase II/III trial of Purlytin

April 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...